Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast plus nasal mometasone versus placebo plus nasal mometasone for adenoid hypertrophy in children
IRCT20180718040520N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in adenoidal hypertrophy comparing Montelukast + nasal mometasone with Placebo + nasal mometasone (2 arms). Primary endpoints: Nasal speech, Sleep snoring and 1 more. Started Apr 2018; status: completed.
02
Drugs
montelukastmometasone
03
Conditions
adenoidal hypertrophy
Beyond the preview
Go deeper on IRCT20180718040520N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180718040520N1.